MedTrace Logo

EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke

NCT03601702 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-16

No results posted yet for this study

Summary

The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

Mechanical thrombectomy with EmboTrap ® II Device

Endovascular treatment with mechanical thrombectomy using EmboTrap ® II Device (Neuravi)

Sponsors & Collaborators

  • Neuravi Limited

    collaborator INDUSTRY

  • Niguarda Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-12-31
Completion
2027-06-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03601702 on ClinicalTrials.gov